Spasticity Treatment Market Size, Share and Industry Analysis with Trends, Forecasts 2019-2025
Spasticity Treatment Market Size, Share and Industry Analysis By Type (Drug Therapy, Physical and Occupational Therapy, Surgery, and Others), By Product (Baclofen, Benzodiazepines, Dantrolene Sodium, Imidazolines, Gabapentin, and Botulinum Toxin (BTA) Injections), By End User (Hospitals and Clinics, Rehabilitation Centers, and Other End Users), By Region (North America, Europe, Asia-Pacific, and Rest of the World), Competitive Market Share & Forecast, 2019 - 2025
The global spasticity treatment market is expected to
reach USD xxx million by 2025 from USD xxx million in 2018, at a CAGR of xx%
during the forecast period. Global Spasticity treatment market report covers
market size, market share and market forecast by type, end user, regions, and key
players, with historical data along with forecast from 2019 to 2025. The report
covers an in depth description, competitive scenario, wide product portfolio of
key vendors and business strategy adopted by competitors along with their SWOT
analysis, revenue, sales and Porter's Five Forces Analysis.
Spasticity
Treatment Market Outlook:
Spasticity
is a medical condition in which certain muscles are continuously contracted.
This continuous contraction causes stiffness or tightness of the muscles and
can interfere with the normal movement, speech and posture. Spasticity is commonly
caused by significant damage to the portion of brain or the spinal cord that
controls one’s voluntary movement. It may also occur along with spinal cord
injury, brain or head trauma, amyotrophic lateral sclerosis, multiple
sclerosis, hereditary spastic paraplegias, cerebral palsy, stroke, and
metabolic diseases such as adrenoleukodystrophy, phenylketonuria, and Krabbe
disease. This damage to the brain or spinal cord results in changing balance of
signals between the nervous system and the muscles. Spasticity is a condition
that negatively affects the muscles and joints of the extremities and mainly
causes harm to the growing children.
Diagnosis
and treatment of spasticity depends on the severity of the spasticity and
disorders associated with it. Treatment alternative of spasticity may include
such medications as baclofen, diazepam, tizanidine or clonazepam. Along with
products, the spasticity treatment market also consists of various therapeutic
services such as physical therapy, speech therapy, and so on. Physical therapy
treatments include muscle stretching and number of motion exercises which help
prevent shrinkage or shortening of muscles. These therapies also help to reduce
the severity of symptoms. Moreover, targeted injection of botulinum toxin administered
into muscles with the most damage can help to selectively weaken these muscles
to improve range of motion and function. In many cases surgeries are also
recommended which would help in tendon release or to sever the nerve-muscle
pathway. These and many such treatment alternatives collaboratively contribute
to the existing market size of the spasticity treatment industry.
Spasticity
Treatment Market
Trends and Advancements:
Spasticity
is a common health condition which affects people with long term neurological
conditions such as multiple sclerosis, stroke, and traumatic brain and spinal
cord injuries. If not treated in time, spasticity can result in severe
complications, such as pressure sores, skin breakdown, urinary tract infections,
and painful limb contractures. As this condition is commonly observed
worldwide, large number research organizations in the spasticity treatment
market are conducting continuous research studies to develop and analyse new
and innovative treatment alternatives. For instance, in 2014 clinical trials
were conducted to study the advances in treatment and management of multiple
sclerosis spasticity. Moreover, introduction of neurostimulation devices is one
of the key trends that is expected to gain traction in the spasticity treatment
market. Number of companies are developing neurostimulation devices to overcome
the adverse effects associated with drugs therapy by treating spasticity in
combination with the available medications. For instance, in April 2016 PathMaker Neurosciences
announced launch of clinical trial, in partnership with Northwell Health to
evaluate the safety and efficacy of MyoRegulator for the treatment of
spasticity.
In
addition to drug therapy, various non-pharmacological therapies are also being
developed and launched in the spasticity treatment market. Scientists conducted
research studies and provided a review of new technologic advances in neuro-rehabilitative
treatments for spasticity in 2017. These studies were conducted to analyse the
effects of physical and occupational therapies provided for spasticity
assessment and treatment. Such studies concluded that inclusion of physical and
occupational therapies in treatment of spasticity are likely to improve the
patient’s condition and prevent them from adverse reactions associated with the
drugs consumed. These and many such studies focus on developing alternative
treatments that would increasing the market size of the spasticity treatment
market and also provide significant growth opportunities to the players
operating this market on local and global level.
Spasticity
Treatment Market Drivers and Restraints:
Globally,
the popularity of physical therapy is drastically increasing, which acts as one
of the key factors driving the growth of global spasticity treatment market. Patients
worldwide are increasingly adopting physical and occupational therapy treatment
for spasticity because it has minimal side effects. Furthermore, several advantages
associated with physiotherapy are encouraging various hospitals to invest in a
physiotherapy centers. Along with this factors such as presence of advanced
drug delivery technology, growing investment development of therapeutic
alternatives, and development of stimulatory devices built in with advanced
technologies are also expected to fuel the growth of spasticity treatment
market during the forecast period. However, factors such as time required to
gain results of physical therapy, and adverse effects associated with drugs
administered are likely to hinder the market growth during the forecast period.
Spasticity
Treatment Market
Segmentation and Geographic Outlook:
The spasticity treatment market is segmented on the
basis of type, end user and geography. On the basis of type, the market is
segmented into drug therapy, physical and occupational
therapy, surgery, and others. Drug
therapy consists of baclofen, benzodiazepines, dantrolene sodium, imidazolines,
gabapentin, and botulinum toxin (BTA) injections. By end user the spasticity
treatment market is segmented into hospitals and clinics, rehabilitation
centers, and other end users. Geographic breakdown and deep analysis of each of
the segments mentioned above is included for North America, Europe, Asia-Pacific,
and Rest of the World. North America is expected to dominate the market by
holding maximum market share of the global spasticity treatment market.
However, Asia-Pacific is expected to experience a fastest growth during the
forecast period. Growing demand for effective therapies and increasing
prevalence of spasticity are the major factors contributing to the growth of spasticity
treatment market in this region.
Spasticity
Treatment Market Competitive Landscape:
The spasticity treatment market appears to be
moderately fragmented and with the presence of several emerging and established
vendors. The companies operating in the market are focusing on developing products
such as neurostimulation devices to treat spasticity in combination with
medications available. Also, the companies are forming strategic alliances with
government organizations to create awareness regarding the symptoms and
treatment alternative available for spasticity. Such activities enable the
companies to mark their presence and gain significant market share in the
global spasticity treatment market.
A comprehensive and competitive analysis of market
leaders is provided in this report. Some of the major players operating in the
global spasticity treatment market include Allergan,
F. Hoffmann-La Roche Ltd., Ipsen Pharma, Pfizer Inc., UCB S.A., Codman & Shurtleff, Inc., Medtronic, Inc., InMed
Pharmaceuticals, Inc., and Orient Pharma Co., Ltd.
What you get from the Spasticity Treatment Market Research Report:
·
The
study provides an in-depth analysis of the spasticity treatment market with
current and future trends to explain the imminent investment pockets in the
market
·
Current
and future trends are outlined to determine the overall attractiveness and to
single out profitable trends to gain a stronger foothold in the market
·
The
report provides information regarding key drivers, restraints and opportunities
with impact analysis
·
Quantitative
analysis of the current market and estimations through 2018-2025 are provided
to showcase the financial caliber of the market
·
Porters
Five Forces model and SWOT analysis of the industry illustrates the potency of
the buyers & suppliers participating in the market
·
Value
chain analysis in the report provides a clear understanding of the roles of
stakeholders involved in the value chain
Choose License Type
Why Choose Us
-
24/5 Research support
Get your queries resolved from an industry expert.
-
Custom research service
Design an exclusive study to serve your research needs.
-
Quality assurance
A testimonial for service in the form of BBB "A" Accreditation.